NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE

NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE

Aim. To assess the effectiveness and safety of a super-selective vasodilating β-adrenoblocker (β-AB) nebivolol in patients with NYHA Functional Class (FC) I–III chronic heart failure (CHF), as a complication of coronary heart disease (CHD). Material and methods. In total, 42 patients with post-infar...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. L. Dzhanaeva, Z. T. Astakhova, V. Yu. Makoeva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2012-02-01
Series:	Российский кардиологический журнал
Subjects:	nebivolol chronic heart failure intracardiac hemodynamics diastolic function
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1193
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

Structural and geometric left ventricular remodeling and systolo-diastolic parameters of intracardiac hemodynamics in isolated obesity
by: S. Yu. Dashutina, et al.
Published: (2005-08-01)

ASSOCIATION BETWEEN CARDIAC ARRHYTHMIAS, INTRACARDIAC AND CENTRAL HEMODYNAMICS IN PATIENTS WITH POST-INFARCTION CARDIOSCLEROSIS AND MITRAL REGURGITATION
by: N. A. Volov, et al.
Published: (2010-04-01)

THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

Intracardiac energy inefficiency during decompensated and compensated heart failure
by: Tetsuma Kawaji, et al.
Published: (2025-02-01)

Changes of endothelial function and intracardiac hemodynamics during implantation of different types of pacemakers
by: V. A. Sanakoeva, et al.
Published: (2019-09-01)

Intracardiac and pulmonary hemodynamics and arterial blood gases in patients with chronic stable angina pectoris associated with chronic obstructive pulmonary disease
by: V. A. Nevzorova, et al.
Published: (1970-01-01)

PERIPHERAL AND INTRACARDIAC VENOUS SYSTEM IN CHRONIC HEART FAILURE AMONG PATIENTS WITH CORONARY HEART DISEASE
by: O. N. Akaemova, et al.
Published: (2009-08-01)

INTRACARDIAC AND CENTRAL HEMODYNAMIC CHANGES IN ELDERLY PATIENTS WITH ISOLATED SYSTOLIC ARTERIAL HYPERTENSION
by: Z. T. Astakhova, et al.
Published: (2009-10-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
by: N. A. Koryagina, et al.
Published: (2014-12-01)

Left ventricular flow dynamics by cardiac imaging techniques in heart failure patients: state of the art
by: Donato Mele, et al.
Published: (2025-05-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

State of intracardiac and central hemodynamics in patients with mitral valve insufficiency during surgery with cardioprotection by electrical fibrillation and intermittent aortic clamping
by: B.M. Todurov, et al.
Published: (2019-12-01)

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS
by: E. I. Bambysheva, et al.
Published: (2016-05-01)

Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
by: Yu. N. Belenkov, et al.
Published: (2011-02-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01)

Metabolite Profiles of Heart Failure, Central Hemodynamic Derangement, and Response to Heart Transplantation
by: Carl Lejonberg, et al.
Published: (2025-07-01)

Serum lipids at various stages and morpho-functional types of heart failure in patients with myocardial infarction
by: S. N. Molchanov, et al.
Published: (2005-04-01)

DAILY CHANGES OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE WITH NIGHT-TIME DYSPNOEA ATTACK
by: S. A. Dovgolis, et al.
Published: (2016-01-01)

NEBIVOLOL SAFETY AS CARDIOSELECTIVE Β-BLOCKER IN COMPLEX THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY CHRONIC OBSTRUCTIVE BRONCHITIS
by: Zh. G. Simonova, et al.
Published: (2003-10-01)

Heart rate variability and central hemodynamic parameters in patients with post3infarctial cardiosclerosis and chronic heart failure
by: A. D. Ibatov, et al.
Published: (2004-06-01)

HEMODYNAMIC AND METABOLIC EFFECTS OF NEBIVOLOL IN LOCOMOTIVE CREW STAFF WITH NEWLY DIAGNOSED ARTERIAL HYPERTENSION
by: I. V. Osipova, et al.
Published: (2016-01-01)

Clinical features of the course of infective endocarditis of prosthetic valves and endocarditis of intracardiac devices
by: V. A. Mosina, et al.
Published: (2024-12-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Modern concept of diastolic heart failure
by: F. T. Ageev
Published: (1970-01-01)

INTRACARDIAC ECHINOCOCCOSIS
by: M. S. Malikova, et al.
Published: (2015-09-01)

MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: A. V. Yezhov, et al.
Published: (2016-01-01)

Diastolic heart failure: boundaries of term application
by: V. V. Kalyuzhin, et al.
Published: (2023-04-01)

AFFECTIVE DISORDERS IN PATIENTS WITH DIASTOLIC CHRONIC HEART FAILURE
by: V. A. Lusov, et al.
Published: (2010-06-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Invasive Hemodynamic Monitoring in Acute Heart Failure and Cardiogenic Shock
by: Luca Baldetti, et al.
Published: (2025-06-01)

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015-09-01)

Assessment of the functional state of left heart in patients with chronic heart failure with preserved ejection fraction
by: D. V. Vdovenko, et al.
Published: (2019-03-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

Dependence of renal filtration capacity on the phenotype of chronic heart failure, indicators of systolic and diastolic heart function
by: V. V. Syvolap, et al.
Published: (2021-05-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)